A Look Back at India’s Top IP Developments of 2023
SpicyIP
DECEMBER 30, 2023
The judgement was passed in a writ petition filed by Natco Pharma against the Controller’s order granting Novartis a patent for a form of the Valsartan-Sacubitril complex, after conducting a unilateral hearing excluding Natco therefrom. Controller of Patents and Designs and Raytheon Company v. In another judgement, Raytheon Company v.
124 
Let's personalize your content